Bulletin
Investor Alert

New York Markets Open in:

Aug. 16, 2021, 1:17 p.m. EDT

Tiziana Life Sciences plc Invites You to Join Us at the Q3 Virtual Investor Summit

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Tiziana Life Sciences Ltd. (TLSA)

or Cancel Already have a watchlist? Log In

London, United Kingdom, Aug 16, 2021 (Newsfile Corp via COMTEX) -- London, United Kingdom--(Newsfile Corp. - August 16, 2021) - Tiziana Life Sciences plc /zigman2/quotes/207307745/composite TLSA -4.32% today announced that Dr. Kunwar Shailubhai, CEO & CSO will be attending the Q3 Virtual Investor Summit.

 

About Tiziana Life Sciences plc

Tiziana Life Sciences plc /zigman2/quotes/207307745/composite TLSA -4.32% is a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology. In addition to Milciclib (a CDK inhibitor being developed in oncology), the Company is also developing Foralumab in COVID-19, multiple sclerosis, and Crohns Disease. Foralumab is the only second generation fully human anti-CD3 monoclonal antibody in clinical development in the world. This Phase 2 compound has potential application in a wide range of autoimmune and inflammatory diseases, such as nonalcoholic steatohepatitis (NASH), ulcerative colitis, multiple sclerosis, type-1 diabetes (T1D), Crohn's disease, psoriasis and rheumatoid arthritis, where modulation of a T-cell response is desirable. The Company is accelerating development of anti-Interleukin 6 receptor (IL6R) mAb, a fully human monoclonal antibody for treatment of IL6-induced inflammatory pulmonary diseases.

For further information:

Tiziana Life Sciences plc
Kunwar Shailubhai
02074952379
info@tizianalifesciences.com

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration

Contact:

Sasha Murray at sasha@investorsummitgroup.com

COMTEX_391660146/2523/2021-08-16T13:16:31

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

copyright (c) newsfile corp. 2021. all rights reserved

/zigman2/quotes/207307745/composite
US : U.S.: Nasdaq
$ 0.68
-0.03 -4.32%
Volume: 132,537
May 24, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$69.16 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/207307745/composite
US : U.S.: Nasdaq
$ 0.68
-0.03 -4.32%
Volume: 132,537
May 24, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$69.16 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.